.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,424,078

« Back to Dashboard

Summary for Patent: 5,424,078

Title: Aqueous ophthalmic formulations and methods for preserving same
Abstract:Stabilized chlorine dioxide is a preservative for ophthalmic formulations. The stabilized chlorine dioxide, when employed as a preservative ophthalmic formulations is preferably present in an amount of from about 0.0002 or about 0.002 to about 0.02 weight/volume percent. The aqueous ophthalmic formulations, in addition to the stabilized chlorine dioxide and the water which functions as a vehicle for the formulations, contains an ophthalmically acceptable tonicity component effective to maintain the osmolality of the formulation at least about 200 mOsmol/kg, and a buffer to maintain the pH of the ophthalmic formulation within an acceptable physiological range. A method for preserving aqueous ophthalmic formulations utilizing stabilized chlorine dioxide is also set forth.
Inventor(s): Dziabo; Anthony J. (El Toro, CA), Ripley; Paul S. (Irvine, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:07/694,640
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 5,424,078

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria147230<disabled in preview>
Australia4549989<disabled in preview>
Australia621689<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc